🧠 Thyroid goiter · hyper/hypo · neoplasia
- Goiter – enlarged thyroid with multiple colloid nodules
- most often euthyroid (normal T4/T3/TSH)
- Plummer syndrome = late hyperthyroidism (toxic multinodular)
- endemic goiter: iodine deficiency (rare in US)
- micro: nodules of varying size, colloid follicles, calcification, hemorrhage, fibrosis
- Hyperthyroidism – ↑ metabolic rate due to ↑ T4/T3
- symptoms: tachycardia, heat intolerance, tremor, diarrhea, weight loss with appetite
- primary hyperthyroidism: ↓ TSH, ↑ free T4
- secondary/tertiary: ↑ TSH, ↑ free T4
- Graves disease – autoimmune (TSI antibodies to TSH receptor)
- female >> male, peak 20–40
- features: hyperthyroidism, diffuse goiter, ophthalmopathy (exophthalmos), pretibial myxedema
- micro: hyperplastic follicles, scalloped colloid
- Hypothyroidism – ↓ metabolic rate due to ↓ T4/T3
- symptoms: fatigue, cold intolerance, myxedema, macroglossia, constipation, anovulation
- primary: ↑ TSH, ↓ free T4
- secondary/tertiary: ↓ TSH, ↓ free T4
- most common cause in US: iatrogenic (post-thyroidectomy / radioactive iodine)
- Thyroiditis
- Hashimoto – autoimmune, most common non-iatrogenic hypothyroidism; female 40–65; painless goiter; risk of B-cell lymphoma; micro: lymphocytic infiltrate, germinal centers, Hürthle cells
- Subacute (de Quervain) – post-viral, tender goiter, transient hyperthyroidism; granulomatous
- Riedel – rare, dense fibrosis, hard thyroid adherent to trachea/esophagus; associated with retroperitoneal fibrosis
- Thyroid neoplasia
- Papillary carcinoma (80%): female 20–50, radiation exposure; RET rearrangements; psammoma bodies, Orphan Annie nuclei, grooves; excellent prognosis
- Follicular carcinoma (15%): female 40–60; hematogenous spread (bone/lung); capsular invasion distinguishes from adenoma
- Medullary carcinoma (5%): C-cell origin, secretes calcitonin; amyloid stroma; 25% familial (MEN2); RET mutations
- Anaplastic – aggressive, >60, rapidly fatal
- TSH is the most sensitive test – normal TSH = euthyroid
🦴 Parathyroid hyper · hypo · brown tumors
- Primary hyperparathyroidism – excess PTH
- causes: adenoma (80%), hyperplasia (15%), carcinoma (rare)
- ↑ serum calcium, ↑ PTH
- manifestations: kidney stones, osteoporosis, osteitis fibrosa cystica (brown tumors), neuropsychiatric
- Secondary hyperparathyroidism – due to hypocalcemia (chronic renal failure, vitamin D deficiency, malabsorption) → compensatory ↑ PTH
- Hypoparathyroidism – low PTH
- causes: surgical removal, DiGeorge, autoimmune (AIRE mutations)
- symptoms: muscle spasms, tingling, prolonged QT, psychiatric
- treatment: vitamin D + calcium
- Osteitis fibrosa cystica = bone resorption, cystic lesions, brown tumors – classic in primary hyperparathyroidism
🧬 Pituitary & Pineal adenomas · DI · SIADH
- Pituitary adenomas – micro (<1cm) vs macro (>1cm); macroadenomas cause visual field defects
- Prolactinoma – most common; galactorrhea, amenorrhea, impotence
- Nonfunctional – hypopituitarism
- GH-producing – gigantism (children) / acromegaly (adults); ↑ IGF-1
- Sheehan syndrome – ischemic necrosis postpartum hemorrhage → panhypopituitarism
- Diabetes insipidus – ADH deficiency (central) or renal resistance (nephrogenic)
- central: head trauma, tumors → hypotonic polyuria, hypernatremia
- nephrogenic: lack of renal response
- SIADH – excess ADH → water retention, hyponatremia, cerebral edema
- common causes: small cell lung cancer, drugs (carbamazepine, SSRIs, cyclophosphamide)
- Craniopharyngioma – Rathke pouch remnant, most common hypopituitarism in children
- Pineal – calcification (landmark); germ cell tumors (rare)
- 75% pituitary destruction → panhypopituitarism (thyroid, adrenal, gonadal axes)
⚡ Adrenal Cushing · aldosterone · insufficiency · pheo
- Cushing syndrome – glucocorticoid excess
- most common: exogenous steroids
- endogenous: Cushing disease (pituitary ACTH), ectopic ACTH (small cell lung), adrenal neoplasm
- clinical: truncal obesity, buffalo hump, moon facies, striae, hypertension, hirsutism
- Hyperaldosteronism – hypertension, hypokalemia
- primary (↓ renin): Conn syndrome (adenoma), bilateral hyperplasia
- secondary (↑ renin): renal artery stenosis
- Adrenogenital syndromes – androgen excess, virilization
- congenital adrenal hyperplasia (21-hydroxylase deficiency most common) or adrenocortical tumor
- Adrenal insufficiency
- Waterhouse-Friderichsen – acute, bilateral hemorrhage, sepsis (N. meningitidis), DIC, shock
- Addison disease – chronic autoimmune destruction; weakness, hyperpigmentation, hypotension, hypoglycemia
- secondary (hypothalamic/pituitary) – no hyperpigmentation (low ACTH)
- Pheochromocytoma – catecholamine-producing tumor (adrenal medulla)
- sustained or episodic hypertension, headache, palpitations, diaphoresis
- rule of 10s: 10% children, bilateral, malignant, familial, extra-adrenal
- elevated urinary VMA & catecholamines; Zellballen pattern
- Dexamethasone suppression test: in Cushing disease (pituitary) → ↓ cortisol; in ectopic/neoplasia → no suppression
🧩 MEN Syndromes MEN1 · MEN2A · MEN2B
- MEN1 (Werner) – pituitary, parathyroid, pancreatic tumors; Zollinger-Ellison; MEN1 gene (menin)
- MEN2A (Sipple) – medullary thyroid carcinoma, pheochromocytoma, parathyroid hyperplasia; RET mutation
- MEN2B – medullary thyroid carcinoma, pheochromocytoma, mucocutaneous neuromas; RET mutation
- Autosomal dominant, incomplete penetrance; tumors occur at young age
🩸 Diabetes Mellitus type 1 · type 2 · complications
- Diagnosis – fasting glucose ≥126 mg/dL (two occasions), or HbA1c ≥6.5%
- Type 1 (10%) – young, autoimmune β-cell destruction (coxsackie B trigger, HLA DR3/DR4)
- absolute insulin deficiency; 3Ps, DKA; insulitis (lymphocytic); treatment: insulin
- Type 2 (90%) – obesity, insulin resistance, relative deficiency
- often asymptomatic; hyperosmolar coma possible; amyloid deposition in islets
- treatment: diet, oral agents, insulin
- Vascular complications – atherosclerosis → MI, stroke, PVD
- nephropathy: glomerular lesions, arteriolosclerosis
- retinopathy: nonproliferative (microaneurysms, exudates) → proliferative (neovascularization)
- neuropathy: peripheral, autonomic (bladder, impotence)
- Myocardial infarction is the most common cause of death in DM
Type 1
• HLA DR3/DR4
• Islet lymphocytic infiltrate
• Ketoacidosis prone
• Insulin dependent
• HLA DR3/DR4
• Islet lymphocytic infiltrate
• Ketoacidosis prone
• Insulin dependent
Type 2
• Obesity association
• Amyloid in islets
• Non-ketotic hyperosmolar coma
• May be managed without insulin
• Obesity association
• Amyloid in islets
• Non-ketotic hyperosmolar coma
• May be managed without insulin